Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06966050 · ClinicalTrials.gov registry record
Multi-center MRD Registry for Inflammatory Breast Cancer
A clinical trial of Breast Cancer, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06966050: Recruiting study of Breast Cancer, sponsored by M.D. Anderson Cancer Center.
NCT06966050 is a study of Breast Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 200 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06966050, a study of Breast Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
To collect data from participants with IBC who may have had MRD testing and may have surgery in the future.
Conditions Studied
Interventions
- BEHAVIORAL Quality-of-life Questionnaire
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-05-05 |
| Est. Completion | 2032-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06966050
The ClinicalTrials.gov registry entry for NCT06966050 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Quality-of-life Questionnaire is the first listed.
NCT06966050 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06966050 about?
NCT06966050 is a clinical study titled "Multi-center MRD Registry for Inflammatory Breast Cancer". To collect data from participants with IBC who may have had MRD testing and may have surgery in the future.
What is the current status of trial NCT06966050?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-05-05. Estimated completion is 2032-05-31.
What conditions does trial NCT06966050 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT06966050?
The interventions under investigation include: Quality-of-life Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT06966050?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06966050 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.